Prudentia Sciences Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$20M
- Investors
-
5
Prudentia Sciences General Information
Description
Developer of drug development platform intended to support AI-powered Asset Diligence and Valuation to De-Risk Investment. The company's platform offers a drug asset marketplace to accelerate drug pipelines, maximize return on investment, and achieve clinical and commercial success for greater patient impact, allowing investors and biopharma clients to effectively position and showcase asset value during portfolio strategy planning and dealmaking.
Contact Information
Website
www.prudentiasciences.comCorporate Office
- Cambridge, MA
- United States
Corporate Office
- Cambridge, MA
- United States
Prudentia Sciences Timeline
Prudentia Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 07-Jan-2026 | $20M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 30-Jul-2024 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Prudentia Sciences Patents
Prudentia Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260195356-A1 | Generating data briefs using generative machine learning models | Pending | 08-Jan-2025 | ||
| WO-2026151895-A1 | Generating data briefs using generative machine learning models | Pending | 08-Jan-2025 |
Prudentia Sciences Signals
Prudentia Sciences Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| McKesson Ventures | Corporate Venture Capital | Minority | ||
| SignalFire | Venture Capital | Minority | ||
| GV | Corporate Venture Capital | Minority | ||
| Iaso Ventures | Venture Capital | Minority | ||
| Virtue (Austin) | Venture Capital | Minority |
Prudentia Sciences FAQs
-
When was Prudentia Sciences founded?
Prudentia Sciences was founded in 2023.
-
Where is Prudentia Sciences headquartered?
Prudentia Sciences is headquartered in Cambridge, MA.
-
What is the size of Prudentia Sciences?
Prudentia Sciences has 14 total employees.
-
What industry is Prudentia Sciences in?
Prudentia Sciences’s primary industry is Business/Productivity Software.
-
Is Prudentia Sciences a private or public company?
Prudentia Sciences is a Private company.
-
What is Prudentia Sciences’s current revenue?
The current revenue for Prudentia Sciences is .
-
How much funding has Prudentia Sciences raised over time?
Prudentia Sciences has raised $27M.
-
Who are Prudentia Sciences’s investors?
McKesson Ventures, SignalFire, GV, Iaso Ventures, and Virtue (Austin) have invested in Prudentia Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process